Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Booming Homology Inks Deal for Huge New Massachusetts HQ

  • Post author:Sam
  • Post published:January 17, 2018
  • Post category:BioPharma

Things are looking up for Massachusetts-based Homology Medicines. Source: BioSpace

Continue ReadingBooming Homology Inks Deal for Huge New Massachusetts HQ

What You Need to Know About CARMA Therapeutics

  • Post author:Sam
  • Post published:January 17, 2018
  • Post category:BioPharma

CARMA Therapeutics is based on technology from the Center for Cellular Immunotherapies at the University of Pennsylvania, and was spun out of the laboratory of Saar Gill, assistant professor of…

Continue ReadingWhat You Need to Know About CARMA Therapeutics

What Happens to the FDA if the Government Shuts Down

  • Post author:Sam
  • Post published:January 17, 2018
  • Post category:BioPharma

The agency would have to furlough about 45 percent of its staff. Source: BioSpace

Continue ReadingWhat Happens to the FDA if the Government Shuts Down

Why a Celgene-Juno Marriage Makes Perfect Sense

  • Post author:Sam
  • Post published:January 17, 2018
  • Post category:BioPharma

Investors and analysts have given it some thought and mostly think it's a sensible acquisition. Source: BioSpace

Continue ReadingWhy a Celgene-Juno Marriage Makes Perfect Sense

3 Broker Favorite Biopharmas Your Portfolio Must Have

  • Post author:Sam
  • Post published:January 17, 2018
  • Post category:BioPharma

These stocks have been given a Strong Buy or Buy rating by 80% or more brokers. Source: BioSpace

Continue Reading3 Broker Favorite Biopharmas Your Portfolio Must Have

Boston's resTORbio Sets Terms for $85M IPO

  • Post author:Sam
  • Post published:January 16, 2018
  • Post category:BioPharma

resTORbio is developing novel therapies to improve immune function in the elderly. Source: BioSpace

Continue ReadingBoston's resTORbio Sets Terms for $85M IPO

How This Little Biopharma Could Beat Amgen, Teva to the Migraine Finish Line

  • Post author:Sam
  • Post published:January 16, 2018
  • Post category:BioPharma

On Jan. 8, Alder BioPharma announced that its eptinezumab met its primary endpoint in its Phase III PROMISE 2 clinical trial for preventing migraine. Source: BioSpace

Continue ReadingHow This Little Biopharma Could Beat Amgen, Teva to the Migraine Finish Line

Aeterna Zentaris Forges $24M Tie-Up With Strongbridge

  • Post author:Sam
  • Post published:January 16, 2018
  • Post category:BioPharma

Strongbridge will fund 70% of the costs of a worldwide pediatric development program to be run by Aeterna Zentaris with customary oversight from a joint steering committee. Source: BioSpace

Continue ReadingAeterna Zentaris Forges $24M Tie-Up With Strongbridge

What You Need to Know About Shepherd Therapeutics

  • Post author:Sam
  • Post published:January 16, 2018
  • Post category:BioPharma

There are many unusual things about Shepherd Therapeutics, but one of them is its origin. Source: BioSpace

Continue ReadingWhat You Need to Know About Shepherd Therapeutics

Novartis' Kymriah Snags Speedy Review From the FDA, EMA

  • Post author:Sam
  • Post published:January 16, 2018
  • Post category:BioPharma

Kymriah became the first CAR-T cell therapy to receive regulatory approval when it was approved by the FDA in August 2017. Source: BioSpace

Continue ReadingNovartis' Kymriah Snags Speedy Review From the FDA, EMA
  • Go to the previous page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.